# Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

> **NCT04496518** · — · ACTIVE_NOT_RECRUITING · sponsor: **Medtronic** · enrollment: 2200 (estimated)

## Conditions studied

- Ventricular Tachycardia

## Interventions

- **DEVICE:** Intrinsic Antitachycardia Pacing (iATP) Therapy

## Key facts

- **NCT ID:** NCT04496518
- **Lead sponsor:** Medtronic
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-08-01
- **Primary completion:** 2024-11-06
- **Final completion:** 2028-01-31
- **Target enrollment:** 2200 (ESTIMATED)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04496518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04496518, "Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04496518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*